A 7-year-old boy is brought to the pediatric clinic for evaluation of tall stature and unusual hand appearance. On examination, the structure marked **A** in the diagram is noted—the child's thumbs protrude beyond the ulnar border of the palm when opposed across it. His arm span exceeds his height by 1.08 times. Echocardiography reveals an aortic root Z-score of 2.1 at the sinuses of Valsalva. Genetic testing confirms a heterozygous mutation in the FBN1 gene on chromosome 15q21. Which of the following best explains the underlying pathophysiology of this patient's connective tissue disorder?

Question

Accepted Answer

A. Loss of fibrillin-1 protein leads to weakened connective tissue scaffold and aberrant TGF-β signaling, causing skeletal and cardiovascular manifestations. ## Why option 1 is correct

The clinical presentation—arachnodactyly (evidenced by the positive Steinberg thumb sign marked as **A**), disproportionately long limbs (arm span-to-height ratio >1.05), and aortic root dilatation—is pathognomonic for Marfan syndrome. The revised Ghent Nosology (2010) and AHA/ACC guidelines establish that Marfan syndrome is caused by autosomal dominant mutations in the FBN1 gene on chromosome 15q21, which encodes fibrillin-1. Fibrillin-1 is a critical glycoprotein that forms the structural scaffold for elastic fibers in connective tissue and sequesters transforming growth factor-beta (TGF-β). Loss of functional fibrillin-1 results in two pathophysiologic consequences: (1) weakened connective tissue throughout the body, manifesting as skeletal features (arachnodactyly, dolichostenomelia, pectus deformities, scoliosis) and (2) aberrant TGF-β signaling, which drives progressive aortic root dilatation and aneurysm formation—the leading cause of mortality if untreated. This dual mechanism is the basis for both beta-blocker therapy (to reduce hemodynamic stress) and losartan (ARB) therapy (to block TGF-β signaling).

## Why each distractor is wrong

- **Option 2**: Describes homocystinuria (cystathionine beta-synthase deficiency), an autosomal recessive disorder. While it can mimic Marfan syndrome with tall stature and lens dislocation, homocystinuria causes inferonasal (not superotemporal) lens displacement, thromboembolism, and megaloblastic anemia—features absent in this patient. The FBN1 mutation excludes this diagnosis.

- **Option 3**: Describes Loeys-Dietz syndrome (TGFBR1/2 mutations), a distinct connective tissue disorder. Although it shares aortic disease with Marfan syndrome, Loeys-Dietz is characterized by bifid uvula, cleft palate, and hypertelorism—not mentioned in this case. The FBN1 mutation and Steinberg sign point to Marfan, not Loeys-Dietz.

- **Option 4**: Describes Ehlers-Danlos syndrome vascular type (COL3A1 mutations encoding type IV collagen). This presents with skin fragility, easy bruising, and spontaneous arterial rupture but lacks the prominent skeletal features (arachnodactyly, dolichostenomelia) and aortic root dilatation pattern seen here. The FBN1 mutation excludes this diagnosis.

**High-Yield:** Marfan syndrome = FBN1 mutation → fibrillin-1 loss → weakened connective tissue + aberrant TGF-β signaling → skeletal features (arachnodactyly, dolichostenomelia) + progressive aortic root dilatation (managed with beta-blockers and losartan).

[cite: Revised Ghent Nosology (2010); AHA/ACC Thoracic Aortic Disease Guidelines; Loeys et al. Nat Rev Dis Primers. 2018]

Answer

B. Mutations in TGFBR1/2 genes result in impaired transforming growth factor-beta receptor signaling with bifid uvula and cleft palate

Answer

C. Deficiency of cystathionine beta-synthase causes homocysteine accumulation, leading to thromboembolism and lens dislocation

Answer

D. Defective type IV collagen in blood vessels predisposes to spontaneous arterial rupture and skin fragility without skeletal features

Explanation

Why option 1 is correct

Why each distractor is wrong

Practice similar questions